

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 6.21650798 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.42877850 |
| 3 | imidazole-containing compound metabolic process (GO:0052803) | 5.18288001 |
| 4 | oligosaccharide catabolic process (GO:0009313) | 5.12046615 |
| 5 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.11509230 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 4.94753652 |
| 7 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.57682292 |
| 8 | glycolipid catabolic process (GO:0019377) | 4.36933150 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.34917032 |
| 10 | interferon-gamma secretion (GO:0072643) | 4.23069912 |
| 11 | regulation of fever generation (GO:0031620) | 4.22286890 |
| 12 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.18385256 |
| 13 | regulation of gene silencing by miRNA (GO:0060964) | 4.18385256 |
| 14 | regulation of gene silencing by RNA (GO:0060966) | 4.18385256 |
| 15 | positive regulation of heat generation (GO:0031652) | 4.08957810 |
| 16 | amino sugar catabolic process (GO:0046348) | 4.08294269 |
| 17 | ceramide catabolic process (GO:0046514) | 4.00730243 |
| 18 | regulation of vitamin metabolic process (GO:0030656) | 3.97996020 |
| 19 | regulation of cholesterol storage (GO:0010885) | 3.95111636 |
| 20 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.90090293 |
| 21 | response to peptidoglycan (GO:0032494) | 3.90031131 |
| 22 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.88727367 |
| 23 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.86117152 |
| 24 | T-helper 1 type immune response (GO:0042088) | 3.84057878 |
| 25 | glycine metabolic process (GO:0006544) | 3.82637975 |
| 26 | regulation of RIG-I signaling pathway (GO:0039535) | 3.77413621 |
| 27 | osteoclast differentiation (GO:0030316) | 3.73274599 |
| 28 | positive regulation of osteoclast differentiation (GO:0045672) | 3.73240686 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.69630661 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 3.69500147 |
| 31 | regulation of podosome assembly (GO:0071801) | 3.69290047 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 3.69110908 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67426130 |
| 34 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.66734290 |
| 35 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.66405540 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.63049717 |
| 37 | membrane lipid catabolic process (GO:0046466) | 3.60198377 |
| 38 | regulation of helicase activity (GO:0051095) | 3.54258030 |
| 39 | regulation of chronic inflammatory response (GO:0002676) | 3.53581759 |
| 40 | nuclear pore organization (GO:0006999) | 3.51868149 |
| 41 | eosinophil chemotaxis (GO:0048245) | 3.51092633 |
| 42 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.47003160 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45339027 |
| 44 | monocyte chemotaxis (GO:0002548) | 3.42859489 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.42029642 |
| 46 | positive regulation of bone remodeling (GO:0046852) | 3.40739662 |
| 47 | positive regulation of bone resorption (GO:0045780) | 3.40739662 |
| 48 | sphingolipid catabolic process (GO:0030149) | 3.40421697 |
| 49 | urea metabolic process (GO:0019627) | 3.36610837 |
| 50 | urea cycle (GO:0000050) | 3.36610837 |
| 51 | natural killer cell mediated immunity (GO:0002228) | 3.36114233 |
| 52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.36114233 |
| 53 | nuclear pore complex assembly (GO:0051292) | 3.34737543 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.31283460 |
| 55 | sphingosine metabolic process (GO:0006670) | 3.31220952 |
| 56 | kynurenine metabolic process (GO:0070189) | 3.30540718 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28015671 |
| 58 | positive regulation of tissue remodeling (GO:0034105) | 3.26532970 |
| 59 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.26468887 |
| 60 | tetrahydrofolate metabolic process (GO:0046653) | 3.23548966 |
| 61 | positive regulation of type 2 immune response (GO:0002830) | 3.23315015 |
| 62 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.21582329 |
| 63 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.16157810 |
| 64 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.15652755 |
| 65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.14904069 |
| 66 | L-phenylalanine metabolic process (GO:0006558) | 3.14904069 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.14445186 |
| 68 | tryptophan catabolic process (GO:0006569) | 3.13642651 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.13642651 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.13642651 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.13287690 |
| 72 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.13284112 |
| 73 | positive regulation of interferon-alpha production (GO:0032727) | 3.13246562 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.10969952 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 3.10385260 |
| 76 | aromatic amino acid family catabolic process (GO:0009074) | 3.10305007 |
| 77 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.08506493 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06695364 |
| 79 | regulation of heat generation (GO:0031650) | 3.05520969 |
| 80 | diol metabolic process (GO:0034311) | 3.05062760 |
| 81 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.03946975 |
| 82 | eosinophil migration (GO:0072677) | 3.03925514 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.02829943 |
| 84 | L-phenylalanine catabolic process (GO:0006559) | 3.02829943 |
| 85 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.01952733 |
| 86 | tryptophan metabolic process (GO:0006568) | 3.01819090 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.01526847 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 3.01420653 |
| 89 | regulation of protein polyubiquitination (GO:1902914) | 3.01148611 |
| 90 | intracellular pH reduction (GO:0051452) | 2.99971906 |
| 91 | positive regulation of protein oligomerization (GO:0032461) | 2.99606680 |
| 92 | positive regulation of protein homooligomerization (GO:0032464) | 2.99554184 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.98569486 |
| 94 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.96374391 |
| 95 | N-acetylneuraminate metabolic process (GO:0006054) | 2.93452499 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 2.93023952 |
| 97 | sulfur amino acid catabolic process (GO:0000098) | 2.92002652 |
| 98 | regulation of prostaglandin secretion (GO:0032306) | 2.88477452 |
| 99 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88388317 |
| 100 | negative regulation of lipid storage (GO:0010888) | 2.87347475 |
| 101 | response to protozoan (GO:0001562) | 2.87073818 |
| 102 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.86992922 |
| 103 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.84774746 |
| 104 | type I interferon signaling pathway (GO:0060337) | 2.83990010 |
| 105 | cellular response to type I interferon (GO:0071357) | 2.83990010 |
| 106 | macrophage activation involved in immune response (GO:0002281) | 2.83453902 |
| 107 | pH reduction (GO:0045851) | 2.81829151 |
| 108 | positive regulation of prostaglandin secretion (GO:0032308) | 2.81102954 |
| 109 | decidualization (GO:0046697) | 2.80578261 |
| 110 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.79871756 |
| 111 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.79402852 |
| 112 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.79164333 |
| 113 | response to type I interferon (GO:0034340) | 2.79115018 |
| 114 | homocysteine metabolic process (GO:0050667) | 2.79102260 |
| 115 | regulation of immunoglobulin secretion (GO:0051023) | 2.77611724 |
| 116 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77021741 |
| 117 | positive regulation of cell size (GO:0045793) | 2.76815805 |
| 118 | determination of adult lifespan (GO:0008340) | 2.76334604 |
| 119 | phospholipid efflux (GO:0033700) | 2.75555467 |
| 120 | cysteine metabolic process (GO:0006534) | 2.75296976 |
| 121 | glyoxylate metabolic process (GO:0046487) | 2.74675088 |
| 122 | folic acid metabolic process (GO:0046655) | 2.74593739 |
| 123 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.73803617 |
| 124 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.73763100 |
| 125 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.73231215 |
| 126 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72194370 |
| 127 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.70582821 |
| 128 | regulation of T-helper cell differentiation (GO:0045622) | 2.70224819 |
| 129 | cellular response to lipopolysaccharide (GO:0071222) | 2.70156343 |
| 130 | response to thyroid hormone (GO:0097066) | 2.69942876 |
| 131 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68609342 |
| 132 | intestinal epithelial cell development (GO:0060576) | 2.68579906 |
| 133 | B cell mediated immunity (GO:0019724) | 2.68486891 |
| 134 | cytokine secretion (GO:0050663) | 2.68133017 |
| 135 | virion attachment to host cell (GO:0019062) | 2.68041820 |
| 136 | adhesion of symbiont to host cell (GO:0044650) | 2.68041820 |
| 137 | regulation of response to interferon-gamma (GO:0060330) | 2.66979349 |
| 138 | positive regulation of cholesterol efflux (GO:0010875) | 2.66396590 |
| 139 | glucosamine-containing compound catabolic process (GO:1901072) | 2.64768881 |
| 140 | growth hormone receptor signaling pathway (GO:0060396) | 2.64249628 |
| 141 | regulation of chemokine biosynthetic process (GO:0045073) | 2.63899373 |
| 142 | dendritic cell differentiation (GO:0097028) | 2.63347305 |
| 143 | serine family amino acid biosynthetic process (GO:0009070) | 2.62939998 |
| 144 | phospholipid homeostasis (GO:0055091) | 2.61222680 |
| 145 | positive regulation of cholesterol transport (GO:0032376) | 2.60884079 |
| 146 | positive regulation of sterol transport (GO:0032373) | 2.60884079 |
| 147 | regulation of histone H3-K9 methylation (GO:0051570) | 2.60622973 |
| 148 | regulation of hypersensitivity (GO:0002883) | 2.58914248 |
| 149 | folic acid-containing compound metabolic process (GO:0006760) | 2.55875439 |
| 150 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.55532156 |
| 151 | regulation of cholesterol esterification (GO:0010872) | 2.54429618 |
| 152 | fatty acid homeostasis (GO:0055089) | 2.52129143 |
| 153 | regulation of integrin activation (GO:0033623) | 2.52094730 |
| 154 | bile acid biosynthetic process (GO:0006699) | 2.51717657 |
| 155 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.50460788 |
| 156 | anterior/posterior axis specification, embryo (GO:0008595) | 2.49974199 |
| 157 | mitotic nuclear envelope disassembly (GO:0007077) | 2.49851136 |
| 158 | one-carbon metabolic process (GO:0006730) | 2.49211412 |
| 159 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.48941144 |
| 160 | protein K6-linked ubiquitination (GO:0085020) | 2.48791882 |
| 161 | purine nucleobase biosynthetic process (GO:0009113) | 2.48626915 |
| 162 | regulation of cholesterol homeostasis (GO:2000188) | 2.48296096 |
| 163 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.47222366 |
| 164 | histone H2A monoubiquitination (GO:0035518) | 2.46384533 |
| 165 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.45622144 |
| 166 | aromatic amino acid family metabolic process (GO:0009072) | 2.45294323 |
| 167 | alpha-amino acid catabolic process (GO:1901606) | 2.45276719 |
| 168 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.44593697 |
| 169 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.44593697 |
| 170 | nucleobase biosynthetic process (GO:0046112) | 2.44511721 |
| 171 | regulation of bile acid biosynthetic process (GO:0070857) | 2.44429271 |
| 172 | regulation of gene silencing (GO:0060968) | 2.43881274 |
| 173 | myeloid dendritic cell activation (GO:0001773) | 2.42846131 |
| 174 | formation of translation preinitiation complex (GO:0001731) | 2.42287489 |
| 175 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.41701149 |
| 176 | cellular response to glucose starvation (GO:0042149) | 2.41426435 |
| 177 | positive regulation of interleukin-12 production (GO:0032735) | 2.41049034 |
| 178 | alkaloid metabolic process (GO:0009820) | 2.40840889 |
| 179 | pore complex assembly (GO:0046931) | 2.40667006 |
| 180 | protein carboxylation (GO:0018214) | 2.40110062 |
| 181 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.40110062 |
| 182 | negative regulation of histone methylation (GO:0031061) | 2.38003228 |
| 183 | mitotic metaphase plate congression (GO:0007080) | 2.35378709 |
| 184 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.34821820 |
| 185 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.34549809 |
| 186 | negative regulation of fibrinolysis (GO:0051918) | 2.33809254 |
| 187 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.32963805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.17236532 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.76244001 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.69334136 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.66837454 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.14688423 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.13930334 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.13930334 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.13930334 |
| 9 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.06518214 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05305581 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.03908360 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97921741 |
| 13 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.85355089 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.83480165 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82822667 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.73152769 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69822463 |
| 18 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.67474544 |
| 19 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.64818557 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.62359628 |
| 21 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.61872848 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.52572825 |
| 23 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.49117053 |
| 24 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44398047 |
| 25 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.37003144 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33887974 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28314305 |
| 28 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.25568361 |
| 29 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.25209045 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18490328 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17629702 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12543396 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05744656 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.03618047 |
| 35 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01629821 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01578187 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98917427 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.95980333 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94382311 |
| 40 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.88969639 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.88823613 |
| 42 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.87059865 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86143194 |
| 44 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86116631 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83865769 |
| 46 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.79257445 |
| 47 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.74005279 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72238112 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71907512 |
| 50 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69770451 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69282458 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67848710 |
| 53 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.67393934 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.66908209 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.63607762 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62565908 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56363732 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55450950 |
| 59 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55200705 |
| 60 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54428622 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54113959 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52492103 |
| 63 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51047334 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50900226 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50414729 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49477978 |
| 67 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47757624 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46654338 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46194486 |
| 70 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.42255670 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41359126 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40839801 |
| 73 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.40356918 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38262399 |
| 75 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.37265375 |
| 76 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37017008 |
| 77 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.35770102 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34646392 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32780920 |
| 80 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.31840238 |
| 81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.31334569 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29748767 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29370667 |
| 84 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.28198410 |
| 85 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.27314059 |
| 86 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.26734745 |
| 87 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.26255482 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25409932 |
| 89 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25324147 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23578486 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22382184 |
| 92 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.22355199 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21189723 |
| 94 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17278842 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15839228 |
| 96 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.15719959 |
| 97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.14300456 |
| 98 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13268292 |
| 99 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12805217 |
| 100 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.12375509 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10673751 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10416286 |
| 103 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10060305 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09795708 |
| 105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09403357 |
| 106 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08883807 |
| 107 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07100858 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06668622 |
| 109 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06246047 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03863702 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03570951 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03100601 |
| 113 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02469587 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02266866 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01247711 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00741342 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00167772 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 0.99844562 |
| 119 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.99592341 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99330118 |
| 121 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99140495 |
| 122 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98362926 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98030365 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97618603 |
| 125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97600509 |
| 126 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97371947 |
| 127 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.96719135 |
| 128 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95873898 |
| 129 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94856430 |
| 130 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94408764 |
| 131 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92634485 |
| 132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92387043 |
| 133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92387043 |
| 134 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91267603 |
| 135 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90828649 |
| 136 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90607071 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89188700 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88547508 |
| 139 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85983085 |
| 140 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85885726 |
| 141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85504231 |
| 142 | MAF_26560356_Chip-Seq_TH1_Human | 0.85239979 |
| 143 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84875221 |
| 144 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.84833187 |
| 145 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83866279 |
| 146 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83843964 |
| 147 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83222711 |
| 148 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83066926 |
| 149 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82231614 |
| 150 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.82127550 |
| 151 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82066343 |
| 152 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82061677 |
| 153 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80170077 |
| 154 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.80121848 |
| 155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79368082 |
| 156 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79360884 |
| 157 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77226132 |
| 158 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77206824 |
| 159 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77143219 |
| 160 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76673325 |
| 161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76632259 |
| 162 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76529980 |
| 163 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.76395320 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75763685 |
| 165 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73944547 |
| 166 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.72159242 |
| 167 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.71785808 |
| 168 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71069999 |
| 169 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70736961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.14739279 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.05623172 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.87860654 |
| 4 | MP0003303_peritoneal_inflammation | 3.84499391 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.68103048 |
| 6 | MP0001348_abnormal_lacrimal_gland | 3.17797327 |
| 7 | MP0008057_abnormal_DNA_replication | 3.10934889 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.94700755 |
| 9 | MP0001346_abnormal_lacrimal_gland | 2.81593579 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.74917857 |
| 11 | MP0000604_amyloidosis | 2.64477920 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.63697880 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.46242346 |
| 14 | MP0000685_abnormal_immune_system | 2.45286466 |
| 15 | MP0005360_urolithiasis | 2.42035772 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.32224939 |
| 17 | MP0005365_abnormal_bile_salt | 2.26932944 |
| 18 | MP0002419_abnormal_innate_immunity | 2.16909748 |
| 19 | MP0009840_abnormal_foam_cell | 2.13728620 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 1.94401085 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.92159802 |
| 22 | MP0003075_altered_response_to | 1.90253611 |
| 23 | MP0003693_abnormal_embryo_hatching | 1.88861800 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.88092008 |
| 25 | MP0005310_abnormal_salivary_gland | 1.84730802 |
| 26 | MP0004510_myositis | 1.80569971 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.80331650 |
| 28 | MP0000343_altered_response_to | 1.79199459 |
| 29 | MP0002009_preneoplasia | 1.73482133 |
| 30 | MP0003252_abnormal_bile_duct | 1.71325108 |
| 31 | MP0003724_increased_susceptibility_to | 1.70022051 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.68651921 |
| 33 | MP0002796_impaired_skin_barrier | 1.68143284 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.66207504 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.59838903 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 1.55745007 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.54716321 |
| 38 | MP0003329_amyloid_beta_deposits | 1.54546671 |
| 39 | MP0000383_abnormal_hair_follicle | 1.53387002 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.49703083 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.48856865 |
| 42 | MP0010307_abnormal_tumor_latency | 1.48854788 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.48267957 |
| 44 | MP0002163_abnormal_gland_morphology | 1.47001476 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.45983100 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.45851401 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.44136202 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43446471 |
| 49 | MP0001819_abnormal_immune_cell | 1.41545432 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.41398115 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.40812939 |
| 52 | MP0003718_maternal_effect | 1.35740175 |
| 53 | MP0000609_abnormal_liver_physiology | 1.30240757 |
| 54 | MP0001727_abnormal_embryo_implantation | 1.30105792 |
| 55 | MP0003077_abnormal_cell_cycle | 1.29257155 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.27272809 |
| 57 | MP0003111_abnormal_nucleus_morphology | 1.25938499 |
| 58 | MP0003941_abnormal_skin_development | 1.23832884 |
| 59 | MP0002090_abnormal_vision | 1.22542936 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.21133766 |
| 61 | MP0004947_skin_inflammation | 1.20238885 |
| 62 | MP0003690_abnormal_glial_cell | 1.18778487 |
| 63 | MP0003186_abnormal_redox_activity | 1.17944894 |
| 64 | MP0002006_tumorigenesis | 1.17482402 |
| 65 | MP0004381_abnormal_hair_follicle | 1.17192535 |
| 66 | MP0005387_immune_system_phenotype | 1.16337155 |
| 67 | MP0001790_abnormal_immune_system | 1.16337155 |
| 68 | MP0002405_respiratory_system_inflammati | 1.15365165 |
| 69 | MP0002653_abnormal_ependyma_morphology | 1.14996928 |
| 70 | MP0009278_abnormal_bone_marrow | 1.13390114 |
| 71 | MP0003436_decreased_susceptibility_to | 1.13246476 |
| 72 | MP0001853_heart_inflammation | 1.13030653 |
| 73 | MP0008058_abnormal_DNA_repair | 1.11864097 |
| 74 | MP0003195_calcinosis | 1.11586342 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.09319945 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.08347077 |
| 77 | * MP0000371_diluted_coat_color | 1.07380120 |
| 78 | MP0000516_abnormal_urinary_system | 1.07267413 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.07267413 |
| 80 | MP0000858_altered_metastatic_potential | 1.05709262 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.03823036 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.02533312 |
| 83 | MP0001800_abnormal_humoral_immune | 1.02387115 |
| 84 | MP0005166_decreased_susceptibility_to | 1.01216369 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.99388050 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.98612685 |
| 87 | MP0000716_abnormal_immune_system | 0.98342019 |
| 88 | MP0005266_abnormal_metabolism | 0.98066672 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 0.96682912 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.95930504 |
| 91 | MP0005501_abnormal_skin_physiology | 0.95180637 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.93691784 |
| 93 | MP0005671_abnormal_response_to | 0.92906755 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.92283197 |
| 95 | MP0001764_abnormal_homeostasis | 0.92084929 |
| 96 | MP0005647_abnormal_sex_gland | 0.91105829 |
| 97 | MP0000627_abnormal_mammary_gland | 0.90251473 |
| 98 | MP0001873_stomach_inflammation | 0.89130991 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.88330757 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.87703022 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.87703022 |
| 102 | MP0005408_hypopigmentation | 0.87584024 |
| 103 | MP0005332_abnormal_amino_acid | 0.87519426 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.87132139 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.84639674 |
| 106 | MP0000920_abnormal_myelination | 0.83793120 |
| 107 | MP0005451_abnormal_body_composition | 0.83372031 |
| 108 | MP0000579_abnormal_nail_morphology | 0.82945575 |
| 109 | MP0001730_embryonic_growth_arrest | 0.82186161 |
| 110 | MP0000613_abnormal_salivary_gland | 0.80007533 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.78368444 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.77881041 |
| 113 | MP0008260_abnormal_autophagy | 0.77829293 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.77531604 |
| 115 | MP0009785_altered_susceptibility_to | 0.77242452 |
| 116 | MP0006082_CNS_inflammation | 0.76719076 |
| 117 | MP0001849_ear_inflammation | 0.76254329 |
| 118 | MP0000598_abnormal_liver_morphology | 0.76064799 |
| 119 | MP0005380_embryogenesis_phenotype | 0.76048714 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.76048714 |
| 121 | MP0005083_abnormal_biliary_tract | 0.75175304 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.74793253 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.73680547 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.73656036 |
| 125 | MP0001191_abnormal_skin_condition | 0.73317088 |
| 126 | MP0002429_abnormal_blood_cell | 0.72822539 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.72766139 |
| 128 | MP0004197_abnormal_fetal_growth/weight/ | 0.72080665 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.71874364 |
| 130 | MP0003890_abnormal_embryonic-extraembry | 0.70847206 |
| 131 | MP0004233_abnormal_muscle_weight | 0.70812198 |
| 132 | MP0009053_abnormal_anal_canal | 0.70212830 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.70166633 |
| 134 | MP0005165_increased_susceptibility_to | 0.69424143 |
| 135 | MP0002398_abnormal_bone_marrow | 0.69126471 |
| 136 | MP0003448_altered_tumor_morphology | 0.68370140 |
| 137 | MP0006054_spinal_hemorrhage | 0.68120515 |
| 138 | MP0005023_abnormal_wound_healing | 0.67370171 |
| 139 | MP0001881_abnormal_mammary_gland | 0.67170259 |
| 140 | MP0002019_abnormal_tumor_incidence | 0.67125181 |
| 141 | MP0002723_abnormal_immune_serum | 0.66943691 |
| 142 | MP0005025_abnormal_response_to | 0.66685782 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.65028374 |
| 144 | MP0009764_decreased_sensitivity_to | 0.63912131 |
| 145 | MP0000569_abnormal_digit_pigmentation | 0.63159301 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.63045999 |
| 147 | MP0000377_abnormal_hair_follicle | 0.62752405 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.62629381 |
| 149 | MP0002098_abnormal_vibrissa_morphology | 0.62482568 |
| 150 | MP0002088_abnormal_embryonic_growth/wei | 0.62260974 |
| 151 | MP0003984_embryonic_growth_retardation | 0.61223187 |
| 152 | MP0008469_abnormal_protein_level | 0.60734965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 8.31879837 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.31879837 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.31879837 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.11505692 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.78227925 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.06194447 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.84928123 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.62002036 |
| 9 | Disinhibition (HP:0000734) | 4.49278155 |
| 10 | Loss of speech (HP:0002371) | 4.04179439 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.86342527 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.84701035 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 3.72117500 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.69186320 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59113326 |
| 16 | Hyperglycinuria (HP:0003108) | 3.58320745 |
| 17 | Mutism (HP:0002300) | 3.57133391 |
| 18 | Diminished motivation (HP:0000745) | 3.45414559 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.45221657 |
| 20 | Apathy (HP:0000741) | 3.43797467 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.42826413 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32491685 |
| 23 | Hyperglycinemia (HP:0002154) | 3.29625637 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.27434126 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.26110436 |
| 26 | Recurrent abscess formation (HP:0002722) | 3.25980836 |
| 27 | Ependymoma (HP:0002888) | 3.18652707 |
| 28 | J-shaped sella turcica (HP:0002680) | 3.18156035 |
| 29 | Lip pit (HP:0100267) | 3.15952675 |
| 30 | Xanthomatosis (HP:0000991) | 3.12745837 |
| 31 | Epidermoid cyst (HP:0200040) | 3.12295741 |
| 32 | Neurofibrillary tangles (HP:0002185) | 3.11875043 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 2.99817353 |
| 34 | Multiple enchondromatosis (HP:0005701) | 2.99476508 |
| 35 | Hydroxyprolinuria (HP:0003080) | 2.96373246 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 2.96373246 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.95363369 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.95363369 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.95363369 |
| 40 | Esophageal varix (HP:0002040) | 2.93290508 |
| 41 | Myocardial infarction (HP:0001658) | 2.88601812 |
| 42 | Deep venous thrombosis (HP:0002625) | 2.86936294 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.86071097 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81878029 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.81878029 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81588475 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.81588475 |
| 48 | Cortical dysplasia (HP:0002539) | 2.80983078 |
| 49 | Hyperammonemia (HP:0001987) | 2.80909059 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.80832784 |
| 51 | Metaphyseal irregularity (HP:0003025) | 2.79556768 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.76260166 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70583371 |
| 54 | Inappropriate behavior (HP:0000719) | 2.61512363 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55278351 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53759685 |
| 57 | Axonal loss (HP:0003447) | 2.53280786 |
| 58 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.52148816 |
| 59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50072535 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.48441899 |
| 61 | Hyperglycemia (HP:0003074) | 2.48396698 |
| 62 | Parakeratosis (HP:0001036) | 2.46838441 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.40833113 |
| 64 | Optic neuritis (HP:0100653) | 2.40833113 |
| 65 | Nuclear cataract (HP:0100018) | 2.40783928 |
| 66 | Increased serum ferritin (HP:0003281) | 2.37434138 |
| 67 | Increased IgE level (HP:0003212) | 2.37223130 |
| 68 | Prostate neoplasm (HP:0100787) | 2.37135298 |
| 69 | Neuronal loss in central nervous system (HP:0002529) | 2.36709948 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.36665343 |
| 71 | Eczematoid dermatitis (HP:0000976) | 2.36607741 |
| 72 | Tetraparesis (HP:0002273) | 2.35974376 |
| 73 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32926755 |
| 74 | Abnormality of the periventricular white matter (HP:0002518) | 2.32229534 |
| 75 | Increased IgM level (HP:0003496) | 2.31827826 |
| 76 | Progressive neurologic deterioration (HP:0002344) | 2.30811175 |
| 77 | Hypochromic anemia (HP:0001931) | 2.30613749 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.26535444 |
| 79 | Glomerulonephritis (HP:0000099) | 2.24854110 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.24581001 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24231622 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.24163475 |
| 83 | Poor head control (HP:0002421) | 2.22896265 |
| 84 | Amaurosis fugax (HP:0100576) | 2.19902533 |
| 85 | Gangrene (HP:0100758) | 2.19343589 |
| 86 | Impulsivity (HP:0100710) | 2.19077017 |
| 87 | Breast hypoplasia (HP:0003187) | 2.17244654 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.17211542 |
| 89 | Global brain atrophy (HP:0002283) | 2.16431461 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.16288424 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.15741687 |
| 92 | Personality changes (HP:0000751) | 2.15576295 |
| 93 | Spastic diplegia (HP:0001264) | 2.15198177 |
| 94 | Stomatitis (HP:0010280) | 2.14231068 |
| 95 | Fat malabsorption (HP:0002630) | 2.13269981 |
| 96 | Oral leukoplakia (HP:0002745) | 2.11840541 |
| 97 | Orchitis (HP:0100796) | 2.11508750 |
| 98 | Abnormality of the salivary glands (HP:0010286) | 2.10958780 |
| 99 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.10359459 |
| 100 | Nausea (HP:0002018) | 2.10352814 |
| 101 | Acute hepatic failure (HP:0006554) | 2.09936504 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.09212932 |
| 103 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.08773840 |
| 104 | Recurrent fungal infections (HP:0002841) | 2.07327255 |
| 105 | Cardiomegaly (HP:0001640) | 2.05186859 |
| 106 | Rhabdomyosarcoma (HP:0002859) | 2.04860841 |
| 107 | Pseudobulbar signs (HP:0002200) | 2.04632620 |
| 108 | Tongue fasciculations (HP:0001308) | 2.04627997 |
| 109 | Dementia (HP:0000726) | 2.04196005 |
| 110 | Premature loss of primary teeth (HP:0006323) | 2.03277325 |
| 111 | Thick nail (HP:0001805) | 2.01581363 |
| 112 | Abnormality of the hepatic vasculature (HP:0006707) | 2.00366739 |
| 113 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99431675 |
| 114 | Palmar hyperkeratosis (HP:0010765) | 1.98589305 |
| 115 | Abnormality of the astrocytes (HP:0100707) | 1.98444258 |
| 116 | Astrocytoma (HP:0009592) | 1.98444258 |
| 117 | Prolonged neonatal jaundice (HP:0006579) | 1.96595103 |
| 118 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96575430 |
| 119 | Abnormality of the gastric mucosa (HP:0004295) | 1.96311401 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 1.95794331 |
| 121 | Joint hemorrhage (HP:0005261) | 1.95646496 |
| 122 | Absent radius (HP:0003974) | 1.95226177 |
| 123 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.95224053 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94492073 |
| 125 | Abnormality of nail color (HP:0100643) | 1.94177918 |
| 126 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.93092997 |
| 127 | Portal hypertension (HP:0001409) | 1.92173515 |
| 128 | Birth length less than 3rd percentile (HP:0003561) | 1.91106883 |
| 129 | Protuberant abdomen (HP:0001538) | 1.90921258 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90914836 |
| 131 | Basal ganglia calcification (HP:0002135) | 1.90712249 |
| 132 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.90442411 |
| 133 | Vertebral clefting (HP:0008428) | 1.90410488 |
| 134 | Polycythemia (HP:0001901) | 1.89118102 |
| 135 | Abnormality of serum amino acid levels (HP:0003112) | 1.88813525 |
| 136 | Complement deficiency (HP:0004431) | 1.88781125 |
| 137 | Muscle fibrillation (HP:0010546) | 1.87834310 |
| 138 | Asplenia (HP:0001746) | 1.87464318 |
| 139 | Biliary tract neoplasm (HP:0100574) | 1.86983798 |
| 140 | Short humerus (HP:0005792) | 1.86855530 |
| 141 | Recurrent skin infections (HP:0001581) | 1.86559010 |
| 142 | Palmoplantar hyperkeratosis (HP:0000972) | 1.85984615 |
| 143 | Albinism (HP:0001022) | 1.85902578 |
| 144 | Bone pain (HP:0002653) | 1.84671757 |
| 145 | Plantar hyperkeratosis (HP:0007556) | 1.84419155 |
| 146 | Agnosia (HP:0010524) | 1.84216835 |
| 147 | Type I diabetes mellitus (HP:0100651) | 1.83730434 |
| 148 | Autoimmune hemolytic anemia (HP:0001890) | 1.83182090 |
| 149 | Generalized aminoaciduria (HP:0002909) | 1.82917805 |
| 150 | Rectovaginal fistula (HP:0000143) | 1.82190170 |
| 151 | Rectal fistula (HP:0100590) | 1.82190170 |
| 152 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80581146 |
| 153 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80581146 |
| 154 | Interstitial pulmonary disease (HP:0006530) | 1.80525125 |
| 155 | Flat occiput (HP:0005469) | 1.80444311 |
| 156 | Neoplasm of the oral cavity (HP:0100649) | 1.80310633 |
| 157 | Ketosis (HP:0001946) | 1.78778369 |
| 158 | Multiple lipomas (HP:0001012) | 1.78553086 |
| 159 | Carpal bone hypoplasia (HP:0001498) | 1.78404862 |
| 160 | Stenosis of the external auditory canal (HP:0000402) | 1.77824022 |
| 161 | Delayed puberty (HP:0000823) | 1.77579701 |
| 162 | IgA deficiency (HP:0002720) | 1.77438779 |
| 163 | T lymphocytopenia (HP:0005403) | 1.77247858 |
| 164 | Absent hand (HP:0004050) | 1.76153003 |
| 165 | Erythroderma (HP:0001019) | 1.74669873 |
| 166 | Abnormality of T cell number (HP:0011839) | 1.74392095 |
| 167 | Aplasia involving forearm bones (HP:0009822) | 1.73613939 |
| 168 | Absent forearm bone (HP:0003953) | 1.73613939 |
| 169 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73409723 |
| 170 | Abnormality of the labia minora (HP:0012880) | 1.73352403 |
| 171 | Glioma (HP:0009733) | 1.73267056 |
| 172 | Abnormality of iron homeostasis (HP:0011031) | 1.72927389 |
| 173 | Symptomatic seizures (HP:0011145) | 1.69509181 |
| 174 | Pulmonary infiltrates (HP:0002113) | 1.65167773 |
| 175 | Vasculitis (HP:0002633) | 1.64981483 |
| 176 | Urticaria (HP:0001025) | 1.64545206 |
| 177 | Dysphonia (HP:0001618) | 1.64401352 |
| 178 | Upper motor neuron abnormality (HP:0002127) | 1.63702482 |
| 179 | Abnormal trabecular bone morphology (HP:0100671) | 1.63672797 |
| 180 | Keratoconjunctivitis sicca (HP:0001097) | 1.63240763 |
| 181 | Gastrointestinal stroma tumor (HP:0100723) | 1.60072065 |
| 182 | Thoracic kyphosis (HP:0002942) | 1.59936778 |
| 183 | Progressive external ophthalmoplegia (HP:0000590) | 1.59659843 |
| 184 | Abnormality of the prostate (HP:0008775) | 1.57229756 |
| 185 | Abnormality of the basal ganglia (HP:0002134) | 1.55268978 |
| 186 | Abnormality of the axillary hair (HP:0100134) | 1.54237830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.85532469 |
| 2 | MAP3K14 | 4.83204937 |
| 3 | EPHA2 | 3.77049768 |
| 4 | CDK12 | 3.50852935 |
| 5 | IKBKB | 2.76982957 |
| 6 | GRK7 | 2.64511467 |
| 7 | CHUK | 2.50335079 |
| 8 | MATK | 2.47765589 |
| 9 | AKT3 | 2.45337311 |
| 10 | TAOK2 | 2.34925525 |
| 11 | TYK2 | 2.20853890 |
| 12 | NEK1 | 2.16371125 |
| 13 | FGFR4 | 2.05597281 |
| 14 | FLT3 | 2.04526664 |
| 15 | WEE1 | 2.03566881 |
| 16 | MAP3K11 | 1.94345368 |
| 17 | PIM2 | 1.86493222 |
| 18 | ADRBK2 | 1.80771167 |
| 19 | DDR2 | 1.75008413 |
| 20 | MAP3K13 | 1.72173705 |
| 21 | FGR | 1.70688859 |
| 22 | DYRK3 | 1.65321398 |
| 23 | TBK1 | 1.65129082 |
| 24 | BCKDK | 1.64987596 |
| 25 | JAK3 | 1.61219305 |
| 26 | RPS6KB2 | 1.56574273 |
| 27 | TTK | 1.54778678 |
| 28 | PBK | 1.54766018 |
| 29 | MAP3K9 | 1.51473408 |
| 30 | NEK2 | 1.47822888 |
| 31 | IRAK3 | 1.45554834 |
| 32 | BLK | 1.40553962 |
| 33 | PIM1 | 1.38983431 |
| 34 | TAF1 | 1.34440852 |
| 35 | PRPF4B | 1.33682410 |
| 36 | MAPKAPK3 | 1.31522184 |
| 37 | ABL2 | 1.31497205 |
| 38 | STK38L | 1.31049847 |
| 39 | MAP3K12 | 1.30165346 |
| 40 | MAP3K10 | 1.29538217 |
| 41 | TSSK6 | 1.28739771 |
| 42 | RIPK4 | 1.25827897 |
| 43 | TAOK1 | 1.20183461 |
| 44 | MAP3K3 | 1.19593354 |
| 45 | ERBB4 | 1.16876181 |
| 46 | TRIB3 | 1.16156380 |
| 47 | PASK | 1.15566743 |
| 48 | DYRK1B | 1.15552813 |
| 49 | STK4 | 1.13081089 |
| 50 | CSF1R | 1.13079976 |
| 51 | IKBKE | 1.11516452 |
| 52 | PRKAA2 | 1.10046068 |
| 53 | LATS1 | 1.09641864 |
| 54 | PLK1 | 1.09239146 |
| 55 | JAK1 | 1.05351854 |
| 56 | IRAK4 | 1.05138278 |
| 57 | SIK3 | 1.03946776 |
| 58 | MST4 | 1.03406728 |
| 59 | BUB1 | 1.02609291 |
| 60 | PTK6 | 1.01747108 |
| 61 | ZAK | 1.01470150 |
| 62 | MUSK | 1.00521658 |
| 63 | CDK4 | 1.00399479 |
| 64 | NEK6 | 1.00255946 |
| 65 | TYRO3 | 0.98973902 |
| 66 | STK3 | 0.97027870 |
| 67 | BMPR2 | 0.94791917 |
| 68 | CDK7 | 0.94388766 |
| 69 | EPHA3 | 0.92370591 |
| 70 | BCR | 0.92172419 |
| 71 | RIPK1 | 0.92039201 |
| 72 | EPHB1 | 0.89536404 |
| 73 | CAMKK2 | 0.88026897 |
| 74 | CHEK2 | 0.86501570 |
| 75 | MAP3K1 | 0.84510076 |
| 76 | MET | 0.84486335 |
| 77 | LIMK1 | 0.84009173 |
| 78 | ICK | 0.83750357 |
| 79 | ACVR1B | 0.80917826 |
| 80 | ALK | 0.80738895 |
| 81 | JAK2 | 0.79662426 |
| 82 | FGFR3 | 0.79266127 |
| 83 | CHEK1 | 0.78709693 |
| 84 | MAP3K8 | 0.78349654 |
| 85 | NEK9 | 0.78316602 |
| 86 | EIF2AK2 | 0.76833614 |
| 87 | EIF2AK3 | 0.76633728 |
| 88 | PAK4 | 0.76140764 |
| 89 | SRPK1 | 0.75698752 |
| 90 | INSRR | 0.75545412 |
| 91 | RPS6KA4 | 0.75082637 |
| 92 | ATR | 0.74864653 |
| 93 | BMX | 0.73939646 |
| 94 | MTOR | 0.71641613 |
| 95 | CDC7 | 0.71023033 |
| 96 | SMG1 | 0.70003697 |
| 97 | TGFBR1 | 0.69961710 |
| 98 | MOS | 0.69838178 |
| 99 | DAPK2 | 0.69298005 |
| 100 | BRSK2 | 0.68156475 |
| 101 | MAP4K1 | 0.68076188 |
| 102 | CDK6 | 0.67585948 |
| 103 | RPS6KA1 | 0.66748506 |
| 104 | MAPK15 | 0.64623442 |
| 105 | BRD4 | 0.64495332 |
| 106 | IRAK2 | 0.64281608 |
| 107 | MELK | 0.63712549 |
| 108 | CDC42BPA | 0.62658169 |
| 109 | DAPK1 | 0.62525584 |
| 110 | SCYL2 | 0.61824515 |
| 111 | TXK | 0.60436355 |
| 112 | MAPK11 | 0.60097662 |
| 113 | RPS6KA2 | 0.59623155 |
| 114 | TLK1 | 0.59547328 |
| 115 | ATM | 0.58528169 |
| 116 | STK10 | 0.57844833 |
| 117 | PRKAA1 | 0.57508096 |
| 118 | MAPKAPK5 | 0.57331942 |
| 119 | AURKB | 0.57018664 |
| 120 | PLK3 | 0.56598726 |
| 121 | GRK6 | 0.54815653 |
| 122 | PKN2 | 0.53809143 |
| 123 | RPS6KB1 | 0.53716624 |
| 124 | SIK1 | 0.53008461 |
| 125 | MAPKAPK2 | 0.52877229 |
| 126 | LYN | 0.52320710 |
| 127 | MAP2K6 | 0.51297247 |
| 128 | GSK3A | 0.50509096 |
| 129 | PDPK1 | 0.50305959 |
| 130 | CDK2 | 0.48813077 |
| 131 | TESK1 | 0.48388563 |
| 132 | CAMK1D | 0.47997672 |
| 133 | MARK3 | 0.47905904 |
| 134 | BRAF | 0.47687353 |
| 135 | STK24 | 0.47357574 |
| 136 | PKN1 | 0.46786359 |
| 137 | CSK | 0.45868169 |
| 138 | CLK1 | 0.45618618 |
| 139 | MAP2K3 | 0.45273245 |
| 140 | PIK3CA | 0.44099147 |
| 141 | TESK2 | 0.44000671 |
| 142 | PLK4 | 0.42013664 |
| 143 | PRKCI | 0.41957616 |
| 144 | AKT1 | 0.41905180 |
| 145 | CAMKK1 | 0.41870313 |
| 146 | RPS6KA5 | 0.41439289 |
| 147 | TTN | 0.41265522 |
| 148 | AURKA | 0.40872452 |
| 149 | RPS6KA6 | 0.40615572 |
| 150 | RPS6KC1 | 0.40572702 |
| 151 | RPS6KL1 | 0.40572702 |
| 152 | PDK1 | 0.40571344 |
| 153 | EIF2AK1 | 0.39872614 |
| 154 | CSNK1D | 0.39102348 |
| 155 | MAP3K5 | 0.38200229 |
| 156 | ABL1 | 0.36768003 |
| 157 | LCK | 0.35655749 |
| 158 | FER | 0.34936860 |
| 159 | MKNK1 | 0.30063546 |
| 160 | LATS2 | 0.30017725 |
| 161 | SYK | 0.28814857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.90116188 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.80572122 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.38148382 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.93857944 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.77818973 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.69169929 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44305870 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.42245230 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.41857112 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.21857148 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.19934102 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15254688 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.08319314 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07903879 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02177354 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.00624744 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.98726718 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96183567 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94252637 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79832039 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76670109 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76239610 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73235799 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64136586 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.62165402 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59424677 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58710473 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57534080 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.56341003 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56150155 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.55174253 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.52513802 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49031457 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48621477 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47919639 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47484602 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40940208 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.38393001 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.36762855 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36448654 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32469346 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31665904 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31010699 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30738079 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29848623 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27881764 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27312547 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26231379 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.24015080 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23814178 |
| 51 | Mismatch repair_Homo sapiens_hsa03430 | 1.22152877 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.19331336 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19096947 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16378891 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16195375 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.15269225 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14780218 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.12436581 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10222681 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 1.10169348 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 1.09752042 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09097578 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06121155 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06074190 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.05840636 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05709503 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04779390 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03786534 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97576054 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.95683587 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.95407835 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93946225 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93598146 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92677222 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92474052 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90847274 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.90464247 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89171058 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89087308 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87162503 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85908001 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85532092 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84296671 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.84019700 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82154918 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81660618 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.80442951 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80158429 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76794235 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76146836 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75758421 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74638896 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73115867 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71645042 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.71434392 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71318898 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70764493 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70161572 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68398104 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68044571 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67261940 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66882607 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66687008 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65552156 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64126418 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.63957115 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63605590 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61177571 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60830907 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60177282 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.59282871 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.56886397 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56212672 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54172694 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54034248 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53306403 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.52565507 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52561190 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.52354487 |
| 120 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52291946 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.52138750 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52117281 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51449797 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.50494906 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50451722 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49718087 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.49340147 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49293676 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48777330 |
| 130 | Measles_Homo sapiens_hsa05162 | 0.48270941 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48170470 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48006330 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47754164 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.47707897 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.47327131 |
| 136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46248748 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46214738 |
| 138 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44876370 |
| 139 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43594374 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41454061 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41067925 |
| 142 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40082445 |
| 143 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39286293 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38558068 |
| 145 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35236089 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32149525 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30898670 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.30181085 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27932495 |
| 150 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25498518 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24630073 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24087472 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24061274 |
| 154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21506620 |
| 155 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21142176 |
| 156 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.20037997 |
| 157 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17837341 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15636229 |
| 159 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11984889 |

